Product
Pharmacological stress agents
1 clinical trial
1 indication
Indication
coronary artery diseaseClinical trial
A Phase 3, Open-Label, Multicentre Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery DiseaseStatus: Completed, Estimated PCD: 2022-05-05